DocGo (DCGO) Projected to Post Earnings on Thursday

DocGo (NASDAQ:DCGO) is expected to issue its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect DocGo to post earnings of ($0.09) per share for the quarter. Interested persons can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Friday, March 6, 2026 at 4:00 PM ET.

DocGo Price Performance

Shares of NASDAQ DCGO opened at $0.74 on Tuesday. DocGo has a 1 year low of $0.66 and a 1 year high of $4.80. The firm has a 50-day simple moving average of $0.84 and a two-hundred day simple moving average of $1.13. The company has a market cap of $72.49 million, a P/E ratio of -1.43 and a beta of 0.95.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on DCGO. Zacks Research upgraded DocGo from a “strong sell” rating to a “hold” rating in a report on Thursday, November 6th. Canaccord Genuity Group reduced their target price on DocGo from $1.60 to $1.50 and set a “buy” rating on the stock in a research note on Wednesday, November 12th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of DocGo in a research report on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $3.21.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of DCGO. Boothbay Fund Management LLC raised its holdings in shares of DocGo by 39.0% in the fourth quarter. Boothbay Fund Management LLC now owns 200,947 shares of the company’s stock valued at $176,000 after acquiring an additional 56,413 shares in the last quarter. Oxford Asset Management LLP increased its position in DocGo by 122.6% during the 2nd quarter. Oxford Asset Management LLP now owns 93,126 shares of the company’s stock valued at $146,000 after purchasing an additional 51,298 shares during the period. Empowered Funds LLC raised its holdings in shares of DocGo by 14.6% in the 4th quarter. Empowered Funds LLC now owns 138,306 shares of the company’s stock valued at $121,000 after purchasing an additional 17,607 shares in the last quarter. BNP Paribas Financial Markets lifted its position in shares of DocGo by 411.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 81,482 shares of the company’s stock worth $111,000 after purchasing an additional 65,545 shares during the period. Finally, Wells Fargo & Company MN lifted its position in shares of DocGo by 44.3% in the 4th quarter. Wells Fargo & Company MN now owns 100,811 shares of the company’s stock worth $88,000 after purchasing an additional 30,957 shares during the period. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

About DocGo

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.